โš™๏ธUBT Bio Tech/Platform

The UBT platform is involved in the overall development of bio-technologies, including medical robot automation and smartification, which require high precision and complexity, as well as the distribution of bio-products. This platform integrates blockchain and payment systems to manage all processes organically and efficiently. Both online and offline distribution channels are seamlessly integrated.

In the United States, development is underway on single-port technology using the da Vinci surgical robot as a leader, as well as micro-surgery robots for minimally invasive procedures. Germany is researching robots that move swiftly and accurately to the target point while minimizing collisions with surrounding tissues. In Japan, the robotics research group at the University of Tokyo is preparing various technologies for the generalization of surgical robots. China is developing technologies utilizing cluster nano-robots for cancer surgery and the treatment of ophthalmic diseases.

The structure of the UBT platform can be better understood through the following data:

In this way, UBT systematically manages the advancement of biotechnology and the distribution of products, and efficiently connects all processes through blockchain and payment systems.

Last updated